Key Financial Inc’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Key Financial Inc’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	–	–	1179
2022 Q1	$0	Hold	150	–	–	﹤0.01%	1123
2021 Q4	$1K	Hold	150	–	–	﹤0.01%	941
2021 Q3	$1K	Hold	150	–	–	﹤0.01%	904
2021 Q2	$1K	Buy	+150	New	+$1.2K	﹤0.01%	847

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Key Financial Inc's SRNE Position: Q2 2022 in Review

Key Financial Inc sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2022, closing a stake of 150 shares.

Key Financial Inc first reported a position in SRNE in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 229 funds tracked by Wall St. Rank hold SRNE as of Q2 2022.

Key Financial Inc reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Key Financial Inc sold 150 Sorrento Therapeutics, Inc. shares in Q2 2022.
Key Financial Inc first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 4 quarters.
Key Financial Inc's Sorrento Therapeutics, Inc. position peaked at $1K in Q4 2021.
229 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2022.

Based on Key Financial Inc's 13F filing for Q2 2022, filed 26 Jul 2022.